Basket

  Untick selected:   0
  1. Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system  / Psota M., Psenkova MB., Racekova N. ... [et al.] .  ClinicoEconomics and Outcomes Research . - Vol. 9 (2017), s. 749—762   [Dokument nie je vo fonde knižnice]
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.